NCT04137900 · Interventional trial
Safety, Tolerability and Pharmacokinetics of a Monoclonal Antibody Specific to B-and T-Lymphocyte Attenuator (BTLA) as Monotherapy and in Combination With an Anti-PD1 Monoclonal Antibody for Injection in Subjects With Advanced Malignancies
Overall registry status Unknown
Phase 1
Conditions Advanced Unresectable Solid Tumor, Metastatic Solid Tumor
Delaware Valley sites
- Thomas Jefferson University · Philadelphia, PA · Philadelphia County · Recruiting
First posted
Registry updated
Added to the directory